Tetsuji Asao - Concepedia

Author

Tetsuji Asao

Taiho Pharmaceutical (Japan)

Also Known As

TETSUJI ASAO, Tetsuji ASAO, Tetsuji Asao

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Taiho Pharmaceutical (Japan)Tokushima University Tokushima Bunri University University College London Cancer Research UK

About

Tetsuji Asao is an author at Taiho Pharmaceutical (Japan) specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	666
2	Natural Sciences	10	12	487
3	Biochemistry	10	10	532
4	Engineering	8	8	146
5	Allergy	2	2	121

Tetsuji Asao

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Structure and activity of specific inhibitors of thymidine phosphorylase to potentiate the function of antitumor 2′-deoxyribonucleosides Masakazu Fukushima, Norihiko Suzuki, Tomohiro Emura, Biochemical Pharmacology Specific InhibitorsMedicinal ChemistryAntitumor 2′-DeoxyribonucleosidesBiochemistryNatural Sciences	2000	236
Antitumor Activity of a Novel Quinoline Derivative, TAS‐103, with Inhibitory Effects on Topoisomerases I and II Teruhiro Utsugi, Kumio Aoyagi, Tetsuji Asao, Japanese Journal of Cancer Research	1997	115
Suppression of Pathogenicity of Porphyromonas gingivalis by Newly Developed Gingipain Inhibitors Tomoko Kadowaki, Atsuyo Baba, Naoko Abe, Molecular Pharmacology	2004	105
Inhibition Mechanism of Cathepsin L-Specific Inhibitors Based on the Crystal Structure of Papain–CLIK148 Complex Hideaki Tsuge, Tomohiro Nishimura, Yukio Tada, Biochemical and Biophysical Research Communications Crystal StructureInhibition MechanismBiochemistryCathepsin L-specific InhibitorsMedicine	1999	102
The Anticancer Natural Product Pironetin Selectively Targets Lys352 of α-Tubulin Takeo Usui, Hiroyuki Watanabe, Hiroshi Nakayama, Chemistry & Biology Medicinal ChemistryMedicineAnti-cancer AgentPharmacologyRadiation Oncology	2004	102
Switch of CD4+ T Cell Differentiation from Th2 to Th1 by Treatment with Cathepsin B Inhibitor in Experimental Leishmaniasis Yoichi Maekawa, Kunisuke Himeno, Hiroyuki Ishikawa, The Journal of Immunology T-regulatory CellImmunologyImmune RegulationImmunologic MechanismAntigen Processing	1998	91
Synthesis and evaluation of 6-methylene-bridged uracil derivatives. Part 2: Optimization of inhibitors of human thymidine phosphorylase and their selectivity with uridine phosphorylase Shingo Yano, Hideki Kazuno, Tsutomu Sato, Bioorganic & Medicinal Chemistry Medicinal ChemistryDerivative (Chemistry)BiochemistryNatural SciencesMedicine	2004	53
A Novel Class of in Vivo Active Anticancer Agents: Achiral<i>seco</i>-Amino- and<i>seco</i>-Hydroxycyclopropylbenz[<i>e</i>]indolone (<i>seco</i>-CBI) Analogues of the Duocarmycins and CC-1065 Atsushi Sato, LuAnne McNulty, Kari Cox, Journal of Medicinal Chemistry	2005	47
TAT-59, a new triphenylethylene derivative with antitumor activity against hormone-dependent tumors Toshiyuki Toko, Yoshikazu Sugimoto, Ken-Ichi Matsuo, European Journal of Cancer and Clinical Oncology Tumor BiologyMedicinal ChemistryAntitumor ActivityEndocrine-related CancerMedicine	1990	39
New Cdc25B Tyrrosine Phosphatase Inhibitors, Nocardiones A and B, Produced by Nocardia sp. TP-A0248. Taxonomy, Fermentation, Isolation, Structural Elucidation and Biological Prbperties. TOSHIO OTANI, Yoshikazu Sugimoto, Yoshimi Aoyagi, The Journal of Antibiotics	2000	39

Page 1